TG Therapeutics Inc. (TGTX)

TG Therapeutics Inc. (TGTX $37.74)
- $37.74 P/E (TTM): 415.22X Cap: $5.96B
- View TGTX Profile
- View Questions on TGTX

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

BioCryst Pharmaceuticals Inc. (BCRX $8.68)
- $8.68 Cap: $1.81B
- View BCRX Profile
- View Questions on BCRX
G1 Therapeutics Inc. (GTHX)
- Cap: $377M
- View GTHX Profile
- View Questions on GTHX
Myovant Sciences Ltd. (MYOV)
- Cap: $2.62B
- View MYOV Profile
- View Questions on MYOV
TG Therapeutics Inc. (TGTX $37.74)
- $37.74 P/E (TTM): 415.22X Cap: $5.96B
- View TGTX Profile
- View Questions on TGTX

Q: Hi 5i,
Need help narrowing this list down to two stocks. Which ones have the best earning or projected earnings and balance sheets. Also what are the analysts saying any additional information is appreciated. Do you have any other ideas for small biotech?
Regards,

Read Answer Asked by Mark on September 14, 2021

Exelixis Inc. (EXEL $45.25)
- $45.25 P/E (TTM): 20.31X Cap: $12.12B
- View EXEL Profile
- View Questions on EXEL
TG Therapeutics Inc. (TGTX $37.74)
- $37.74 P/E (TTM): 415.22X Cap: $5.96B
- View TGTX Profile
- View Questions on TGTX
Veritone Inc. (VERI $2.82)
- $2.82 Cap: $102M
- View VERI Profile
- View Questions on VERI
Agora Inc. (API $4.01)
- $4.01 Cap: $379M
- View API Profile
- View Questions on API
Atomera Incorporated (ATOM $5.26)
- $5.26 Cap: $162M
- View ATOM Profile
- View Questions on ATOM
Affirm Holdings Inc. (AFRM $65.71)
- $65.71 Cap: $21.17B
- View AFRM Profile
- View Questions on AFRM

Q: (Part 2 with 6 new companies) I watched a presentation on Saturday where analysts fielded audience company suggestions and whittled them down to a few that they felt could 10 X in a reasonable time frame. I am wondering if you can look at this six and rank based on potential? For the top two, it would be great if you can discuss the TAM, impact of market value and shares outstanding, if they are solving a new problem/creating a new market and quality of management. Basically, why those two?

ATOM
API
AFRM
VERI
TGTX
EXEL

Read Answer Asked by Tim on February 12, 2021